Plasma ghrelin and gastric pacing in morbidly obese patients

Metabolism: Clinical and Experimental

Volumn 56, Issue 8, 2007, Pages 1017-1021

  Cigaina, Valerio ^a   Hirschberg, Angelica Lindén ^b  

^a Hospital of Mestre   (Italy)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

GHRELIN;

ADULT; ARTICLE; BODY MASS; CLINICAL ARTICLE; CONTROLLED STUDY; FEEDING BEHAVIOR; FEMALE; HUMAN; LIFESTYLE MODIFICATION; MALE; OBESITY; PACEMAKER ELECTRODE; PRIORITY JOURNAL;

ADULT; BODY MASS INDEX; EATING; ELECTRIC STIMULATION THERAPY; ELECTRODES, IMPLANTED; FEMALE; HUMANS; MALE; OBESITY, MORBID; PEPTIDE HORMONES; RADIOIMMUNOASSAY; STOMACH; WEIGHT LOSS;

EID: 34347378868     PISSN: 00260495     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.metabol.2007.03.007     Document Type: Article

References (37)

1. Haslam D. Obesity-time to wake up. BMJ 333 (2006) 640-642
2. Fobi M.A., Lee H., Felahy B., Che K., Ako P., and Fobi N. Choosing an operation for weight control, and the transected banded gastric bypass. Obes Surg 15 (2005) 114-1121
3. Cigaina V., Pinato G.P., Rigo V., et al. Gastric peristalsis control by mono situ electrical stimulation: a preliminary study. Obes Surg 6 (1996) 247-249
4. Cigaina V., Saggioro A., Rigo V., et al. Long-term effects of gastric pacing to reduce feed intake in swine. Obes Surg 6 (1996) 250-253
5. Cigaina V. Gastric pacing as therapy for morbid obesity: preliminary results. Obes Surg 12 Suppl 1 (2002) 12S-16S
6. D'Argent J. Gastric electrical stimulation as therapy of morbid obesity: preliminary results from the French study. Obes Surg 12 (2002) 21S-25S
7. Cigaina V. Long-term follow-up of gastric stimulation for obesity: the Mestre 8-year experience. Obes Surg 14 Suppl 1 (2004) S14-S22
8. Favretti F., De Luca M., Segato G., et al. Treatment of morbid obesity with the Transcend Implantable Gastric Stimulator (IGS): a prospective survey. Obes Surg 14 (2004) 666-670
9. Cigaina V., and Hirschberg A.L. Gastric pacing for morbid obesity: plasma levels of gastrointestinal peptides and leptin. Obes Res 11 (2003) 1456-1462
10. Kojima M., Hosoda H., Date Y., Nakazato M., Matsuo H., and Kangawa K. Ghrelin is a growth-hormone-releasing peptide from stomach. Nature 402 (1999) 656-660
11. Date Y., Kojima M., Hosoda H., et al. Ghrelin, a novel growth hormone-releasing acylate peptide, is synthesized in a distinct endocrine cell type in the gastrointestinal tracts of rats and humans. Endocrinology 141 (2000) 4255-4261
12. Hosoda H., Kojima M., Matsuo H., and Kangawa K. Purification and characterization of rat des-Gln14-Ghrelin, a second endogenous ligand for the growth hormone secretagogue receptor. J Biol Chem 275 (2000) 21995-22000
13. Kojima M., Hosoda H., and Kangawa K. Purification and distribution of ghrelin: the natural endogenous ligand for the growth hormone secretagogue receptor. Horm Res 56 Suppl 1 (2001) 93-97
14. Wren A.M., Seal L.J., Cohen M.A., Brynes A.E., Frost G.S., Murphy K.G., et al. Ghrelin enhances appetite and increases food intake in humans. J Clin Endocrinol Metab 86 (2001) 5992
15. Date Y., Murakami N., Toshinai K., Matsukura S., Niijima A., Matsuo H., et al. The role of the gastric afferent vagal nerve in ghrelin-induced feeding and growth hormone secretion in rats. Gastroenterology 123 (2002) 1120-1128
16. Ruter J., Kobelt P., Tebbe J.J., Avsar Y., Veh R., Wang L., et al. Intraperitoneal injection of ghrelin induces Fos expression in the paraventricular nucleus of the hypothalamus in rats. Brain Res 991 (2003) 26-33
17. Cummings D.E., Purnell J.Q., Frayo R.S., et al. A preprandial rise in plasma ghrelin levels suggests a role in meal initiation in humans. Diabetes 50 (2001) 1714-1719
18. Shiiya T., Nakazato M., Mizuta M., et al. Plasma ghrelin levels in lean and obese humans and the effect of glucose on ghrelin secretion. J Clin Endocrinol Metab 87 (2002) 240-244
19. Tschöp M., Weyer C., Tataranni P.A., Devanarayan V., Ravussin E., and Heiman M.L. Circulating ghrelin levels are decreased in human obesity. Diabetes 50 (2001) 707-709
20. Cummings D.E., Weigle D.S., Frayo R.S., et al. Plasma ghrelin levels after diet induced weight loss or gastric bypass surgery. N Engl J Med 346 (2002) 1623-1630
21. English P.J., Ghatei M.A., Malik I.A., Bloom S.R., and Wilding J.P.H. Food fails to suppress ghrelin levels in obese humans. J Clin Endocrinol Metab 87 (2002) 2984-2987
22. De Luca M., Segato G., Busetto L., Favretti F., Aigner F., Weiss H., et al. Progress in implantable gastric stimulation: summary of results of the European multi-center study. Obes Surg 14 (2004) S33-S39
23. Broglio F., Gottero C., Prodam F., Gauna C., Muccioli G., Papotti M., et al. Non-acylated ghrelin counteracts the metabolic but not the neuroendocrine response to acylated ghrelin in humans. J Clin Endocrinol Metab 89 (2004) 3062-3065
24. Williams D.L., Grill H.J., Cummings D.E., and Kaplan J.M. Vagotomy dissociates short- and long-term controls of circulating ghrelin. Endocrinology 144 (2003) 5184-5187
25. Sugina T., Yamaura J., Yamagishi M., Kurose Y., Kojima M., Kangawa K., et al. Involvement of cholinergic neurons in the regulation of the ghrelin secretory response to feeding in sheep. Biochem Biophys Res Com 304 (2003) 308-312
26. Heath R.B., Jones R., Frayn K.N., and Robertson M.D. Vagal stimulation exaggerates the inhibitory ghrelin response to oral fat in humans. J Endocrinol 180 (2004) 273-281
27. Liu J., Qiao X., and Chen J.D.Z. Vagal afferent is involved in short-pulse gastric electrical stimulation in rats. Dig Dis Sci 49 (2004) 729-737
28. Stoeckli R., Chanda R., Langer I., and Keller U. Changes of body weight and plasma ghrelin levels after gastric banding and gastric bypass. Obes Res 12 (2004) 346-350
29. Schindler K., Prager G., Ballaban T., Kretschmer S., Reiner R., Buranyi B., et al. Impact of laparoscopic adjustable gastric banding on plasma ghrelin, eating behaviour and body weight. Eur J Clin Invest 34 (2004) 549-554
30. Hanusch-Enserer U., Cauza E., Brabant G., Dunky A., Rosen H., Pacini G., et al. Plasma ghrelin in obesity before and after weight loss after laparoscopical adjustable gastric banding. J Clin Endocrinol Metab 89 (2004) 3352-3358
31. Nijhuis J, van Dielen FMH, Buurman WA, Greve JWM. Ghrelin, leptin and insulin levels after restrictive surgery: a 2-year follow-up study. Obes Surg 2004;14-783-787.
32. Geloneze B., Tambascia M.A., Pilla V.F., Geloneze S.R., Repetto E.M., and Pareja J.C. Ghrelin: a gut-brain hormone: effect of gastric bypass surgery. Obes Res 13 (2003) 17-22
33. Tritos N.A., Mun E., Bertkau A., Grayson R., Maratos-Flier E., and Goldfine A. Serum ghrelin levels in response to glucose load in obese subjects post-gastric bypass surgery. Obes Res 11 (2003) 919-924
34. Morinigo R., Casamitjana R., Moizé V., Lacy A.M., Delgado S., Gomis R., et al. Short-term effects of gastric bypass surgery on circulating ghrelin levels. Obes Res 12 (2004) 1108-1116
35. Frübeck G., Diez-Caballero A., Jesús Gil M., Montero I., Gómez-Ambrosi J., Salvador J., et al. The decrease in plasma ghrelin concentrations following bariatric surgery depends on the functional integrity of the fundus. Obes Surg 14 (2004) 606-612
36. Wang G.J., Yang J., Volkow N.D., Telang F., Ma Y., Zhu W., et al. Gastric stimulation in obese subjects activates the hippocampus and other regions involved in brain reward circuitry. Proc Natl Acad Sci U S A 103 (2006) 15641-15645
37. Fukuda H., Mizuta Y., Isomoto H., Takeshima F., Ohnita K., Ohba K., et al. Ghrelin enhances gastric motility through direct stimulation of intrinsic neural pathways and capsaicin-sensitive afferent neurones in rats. Scand J Gastroenterol 39 (2004) 1209-1214